Pediatric brain tumors
Normal neuronal precursor cell proliferation, survival and migration in order to identify pathways that are likely to contribute to the genetics of pediatric brain tumors. We described a critical role for the chemokine receptor CSCR4 in normal cerebellar development and malignant brain tumor growth. This requirement creates a unique vulnerability in cancer growth to CXCR4 blockade, and we hope to exploit this in novel treatments for pediatric and adult patients with brain tumors.
- 1992: MSc, neuroscience, Albert Einstein College of Medicine, New York
- 1994: MD/PhD, neuroscience, Albert Einstein College of Medicine
- 1994 - 1997: Resident, Children's Hospital and Harvard University, Boston
- 1997 - 2000: Clinical fellow, hematology/oncology, Children's Hospital and Dana-Farber Cancer Institute, Boston
- 2000: American Board of Pediatrics, Pediatric Hematology/Oncology
Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.